Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 12, 1996, Pages 1308-1314

  Timour, Quadiri ^a   Aupetit, Jean François ^a   Freysz, Marc ^a   Frassati, Dominique ^a   Faucon, Georges ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Amlodipine; Calcium antagonists; Dihydropyridines; Ischemic ventricular fibrillation; Transitory myocardial ischemia

Indexed keywords

AMLODIPINE;

ACTION POTENTIAL; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; ST SEGMENT; SWINE; T WAVE;

EID: 0030436535     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y96-139     Document Type: Article

References (43)

1. Anderson, J.L., Rodier, H.E., and Green, L.S. 1983. Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold. Am. J. Cardiol. 51: 1196-1202.
2. Aupetit, J.F., Timour, Q., Chevrel, G., Loufoua-Moundanga, J., Omar, S., and Faucon, G. 1993. Attenuation of the ischemia-induced fall of electrical threshold for fibrillation by a calcium antagonist, diltiazem. Naunyn Schmiedebergs Arch. Pharmacol. 348: 509-514.
3. Aupetit, J.F., Timour, Q., Freysz, M., Loufoua-Moundanga, J., Omar, S., Chevrel, G., and Faucon, G. 1994. Vulnerability to ventricular fibrillation related to ischemia. Comparison of the acute effects of β-blockers and calcium antagonists. Arch. Int. Pharmacodyn. 327: 25-39.
4. Aupetit, J.F., Timour, Q., Loufoua-Moundanga, J., Barral-Cadière, L., Lopez, M., Freysz, M., and Faucon, G. 1995. Profibrillatory effects of lidocaine in the acutely ischemic porcine heart. J. Cardiovasc. Pharmacol. 25: 810-816.
5. + accumulation. Eur. J. Pharmacol. 127: 261-265.
6. Brooks, W.W., Verrier, R.L., and Lown, B. 1980. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Cardiovasc. Res. 14: 295-302.
7. Clusin, W.T., Buchbinder, M., Ellis, A.K., Kernoff, R.S., Giacomini, J.C., and Harrison, D.C. 1984. Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Circ. Res. 54: 10-20.
8. Coraboeuf, E. 1978. Ionic basis of electrical activity in cardiac tissues. Am. J. Physiol. 234: H101-H116.
9. DAVIT I (Danish Study Group on Verapamil in Myocardial Infarction; Danish Verapamil Infarction Trial). 1984. Verapamil in acute myocardial infarction. Eur. Heart J. 5: 516-528.
10. DAVIT II (Danish Verapamil Infarction Trial II). 1990. Effect of verapamil on mortality and major events after acute myocardial infarction. Am. J. Cardiol. 66: 779-785.
11. Dodd, M.G., Gardiner, D.G., Carter, A.J., Sutton, M.R., and Burges, R.A. 1989.The haemodynamic properties of amlodipine in anaesthetized and conscious dogs: comparison with nitrendipine and influence of β-adrenergic blockade. Cardiovasc. Drugs Ther. 3: 545-555.
12. Elharrar, V., Gaum, W.E., and Zipes, D.P. 1977. Effects of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am. J. Cardiol. 39: 544-549.
13. Fondacaro, J.D., Han, J., and Yoon, M.S. 1978. Effects of verapamil on ventricular rhythm during acute coronary occlusion. Am. Heart J. 96:81-86.
14. Fujimoto, T., Peter, T., Hamamoto, H., McCullen, A.E., and Mandel, W.J. 1981. Effects of nifedipine on conduction delay during ventricular myocardial ischemia and reperfusion. Am. Heart J. 102: 45-52.
15. Gettes, L.S., Cascio, W.E., Johnson, T., and Fleet, W.F. 1991. Local myocardial biochemical and ionic alterations during myocardial ischemia and reperfusion. Drugs, 42(Suppl. 1): 7-13.
16. Hagar, J.M., Hale, S.L., and Kloner, R.A. 1991. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary occlusion and reperfusion in the rat. Circ. Res. 68: 61-68.
17. Hansen, J.F. 1991. Treatment with verapamil after acute myocardial infarction. Drugs, 42(Suppl. 2): 43-53.
18. Heijnis, J.B., Coronel, R., and Van Zwieten, P.A. 1991. The effects of calcium antagonists on extracellular potassium accumulation during global ischemia in isolated perfused rat hearts. Cardiovasc. Drugs Ther. 5: 1035-1041.
19. Held, P.H., Yusuf, S., and Furberg, C.D. 1989. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br. Med. J. 299: 1187-1192.
20. James, R.G.G., Arnold, J.M.O., Allen, J.D., Pantridge, J.F., and Shanks, R.G. 1977. The effect of heart rate, myocardial ischemia and vagal stimulation on the threshold for ventricular fibrillation. Circulation, 55: 311-317.
21. Janse, M.J., and Wit, A.L. 1989. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69: 1049-1169.
22. Kaumann, A.J., and Aramendia, P. 1968. Prevention of ventricular fibrillation induced by coronary ligation. J. Pharmacol. Exp. Ther. 64: 326-332.
23. Kimura, S., Bassett, A.L., Kohya, T., Kozlovski, P.L., and Myerburg, R.J. 1987. Regional effect of verapamil on recovery of excitability and conduction time in experimental ischemia. Circulation, 76: 1146-1154.
24. Kjekshus, J.K. 1986. Importance of heart rate in determining beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am. J. Cardiol. 57: 43F-49F.
25. Kloner, R.A., and Braunwald, E. 1987. Effects of calcium antagonists on infarcting myocardium. Am. J. Cardiol. 59: 84B-94B.
26. Lange, R.L., Ingwall, J., Hale, S.L., Alker, K.J., Braunwald, E., and Kloner, R.A. 1984. Preservation of high energy phosphates by verapamil in reperfused myocardium. Circulation, 70: 734-741.
27. Lyons, C.J., Burgess, M.J., and Abildskov, J.A. 1977. Effects of acute hyperkalemia on cardiac excitability. Am. Heart J. 94: 755-763.
28. MDPIT (Multicenter Diltiazem Postinfarction Trial Research Group). 1988.The effect of diltiazem on mortality and reinfarction after myocardial infarction. N. Engl. J. Med. 319: 385-392.
29. Murry, C.E., Jennings, R.B., and Reimer, K.A. 1986. Preconditioning with ischemia: a delay in lethal cell injury in ischemic myocardium. Circulation, 74: 1124-1136.
30. Nakaya, H. 1982. Effect of verapamil on conduction delay and potassium efflux induced by global ischemia in isolated rabbit hearts. Eur. J. Pharmacol. 79: 185-192.
31. Nanas, J.N., and Kralios, A. 1986. Relative effects of propranolol and timolol on ventricular fibrillation threshold and hemodynamics in the dog. Am. Heart J. 111: 1094-1100.
32. Peter, T., Fujimoto, T., Hamamoto, H., and Mandel, W.J. 1983. Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation. Am. Heart J. 106: 1023-1028.
33. Rehnqvist, N. 1990. Prevention of sudden death by beta-blockade. Cardiovasc. Drugs Ther. 4: 675-680.
34. Reuter, H. 1984. Ion channels in cardiac cell membrane. Annu. Rev. Physiol. 46: 473-484.
35. Roeland, J., Klootwijk, P., Lubsen, J., and Janse, M.J. 1984. Sudden death during long-term ambulatory monitoring. Eur. Heart J. 5: 7-20.
36. Stopher, D.A., Beresford, A.P., Macrae, P.V., and Humphrey, M.J. 1988. The metabolism and pharmacokinetics of amlodipine in humans and animals. J. Cardiovasc. Pharmacol. 12(Suppl. 7): S55-S59.
37. Surawicz, B. 1982. Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia. Am. Heart J. 103: 698-706.
38. Thandroyen, F.T. 1982. Protective action of calcium channel antagonist agents against ventricular fibrillation in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 14: 21-32.
39. Timour, Q., Bertrix, L., Bouzouita, K., Lang, J., and Faucon, G. 1983. Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ. Arch. Int. Pharmacodyn. 261: 238-248.
40. Timour, Q., Larbre, J.P., Aupetit, J.F., Gerentes-Chassagne, I., Loufoua-Moundanga, J., Kioueh, I., and Faucon, G. 1991. Protection against ischemic ventricular fibrillation by blocking agents of myocardial cell calcium influx. Electrophysiological study in the pig in situ heart. Fundam. Clin. Pharmacol. 5: 641-644.
41. Vegh, A., Komori, S., Szekeres, L., and Parratt, J.R. 1992. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc. Res. 26: 487-495.
42. Weidmann, S. 1955. The effect of the cardiac membrane potential on the rapid availability of sodium carrying system. J. Physiol. (London), 127:213-214.
43. Williams, D.M., and Cubeddu, L. 1988. Amlodipine pharmacokinetics in healthy volunteers. J. Clin. Pharmacol. 28: 990-994.